Effects of a 6-Month Gymnastics Program on Somatotype and Motor Performance in Children Across Age Groups (Motor Progress)
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
The study design for the present investigation was prospective, controlled, and observational with a duration of 6 months. The repeated measures design approach has been used to assess the neuromuscular and morphological adaptations (Pre-test vs. Post-test) for the gymnastics and inactive groups. The intervention and observation period for the study was 2 days x 24 weeks.
To ensure high internal validity and to minimize the effects of circadian rhythm changes, all pre- and post-test assessments were conducted during the morning hours, between 09:00 and 11:30 AM, under similar environmental conditions (temperature and humidity). Prior to the pre-test, standardized pre-test procedures were clearly explained to the participants and their parents. Children were instructed to adhere to their routine sleeping habits (minimum 8 hours of sleep) and abstain from any strenuous physical activity and sports for at least 24 hours prior to the pre- and post-test assessments.
With regard to the standardized nutritional conditions, the participants were instructed to adhere to their routine diet but abstain from heavy meals for at least 2 hours prior to the pre- and post-test assessments. Participants were allowed to drink water ad libitum up to 30 minutes prior to the assessments.
On the assessment days, a logical and non-fatiguing sequence of the pre- and post-test assessments was strictly followed. Non-invasive anthropometric assessments such as stature, body mass, skinfolds, girths, and breadths were conducted for all the participants, while they were in a rested and non-sweated condition. After the anthropometric assessments, the participants were administered a standardized 10-minute dynamic warm-up procedure by a certified strength and conditioning specialist. Subsequently, the motor performance tests were conducted. To prevent the participants from fatigue, the physical tests were conducted from the least to the most fatiguing, from flexibility to muscular endurance and sprint capacity, with strict adherence to the intervening time of 3-5 minutes between the assessments
.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Astana, Kazajstán
- Kazakh National University of Sports
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- For Experimental Group: Active and continuous participation in a gymnastics program during the entire 6-month period.
- Inactive control group : comprised participants who did not practice any form of sports, athletics, and physical training outside their usual physical education classes at school.
Exclusion Criteria:
- the presence of any chronic metabolic, cardiovascular, and endocrine disorders;
- a history of severe musculoskeletal injuries and orthopedic surgeries within the past year;
- the use of medications known to have a significant impact on body composition and physical performance; and
- an attendance rate of less than 85% for the gymnastics sessions (only for the intervention group).
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Grupo experimental
|
Gymnastic Training for six month
|
|
Sin intervención: Grupo de control
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Circumferences (Girths) Measurements
Periodo de tiempo: 6 month
|
Girth measurements were taken to the nearest 0.1 cm using a flexible, non-stretchable anthropometric tape measure (Lufkin W606PM, Apex Tool Group).
The measured girths included the head, neck, shoulder, chest, waist, hip, relaxed arm, forearm, thigh, maximum calf, and ankle circumferences.
Care was taken to ensure the tape measure was at a right angle to the long axis of the body segment and did not compress the subcutaneous tissue.
|
6 month
|
|
Skinfold Thickness Measurements
Periodo de tiempo: 6 month
|
Skinfold thicknesses were measured to the nearest 0.1 mm using a Harpenden skinfold caliper (Baty International, West Sussex, UK).
Measurements were taken in duplicate at nine standardized sites: triceps, subscapular, biceps, chest, axillary, abdominal, suprailiac, anterior thigh, and medial calf.
If the difference between the first two measurements exceeded 5%, a third measurement was taken, and the median value was recorded for analysis.
Furthermore, to obtain a comprehensive and robust quantification of total subcutaneous adiposity, the sum of all nine measured skinfolds (Σ9SF) was calculated.
In pediatric kinanthropometry, the absolute sum of multiple skinfold sites is widely recognized as a highly reliable proxy for total body fatness, as it circumvents the inherent biological maturation errors and prediction biases associated with population-specific body density and body fat percentage equations.
|
6 month
|
|
Waist-to-Height Ratio
Periodo de tiempo: Six Month
|
Calculated by dividing waist circumference (cm) by standing height (cm).
This ratio serves as a highly validated, age-independent proxy for central adiposity and health risk in pediatric populations.
|
Six Month
|
|
Segment Lengths and Bone Breadths Measurements
Periodo de tiempo: Six Month
|
Segment lengths (arm span, total arm, forearm, total leg, thigh, tibia, and foot lengths) were measured using a segmometer and anthropometric tape to the nearest 0.1 cm.
Skeletal breadths were measured to the nearest 0.1 cm using a sliding spreading caliper.
The breadth measurements included the shoulder, biacromial, biiliac, bitrochanteric, knee (biepicondylar femur), elbow (biepicondylar humerus), and wrist.
|
Six Month
|
|
Body Fat (BF) and Fat-Free Mass
Periodo de tiempo: six month
|
Relative body fat percentage (BF%) was estimated using the pediatric-specific skinfold equations developed by Slaughter et al.
Specifically, this calculation utilized the sum of the triceps and subscapular skinfold thicknesses, adjusted for biological sex and maturation, which is considered the gold standard for clinical field assessments in youth.
Subsequently, total body fat mass was determined, and absolute Fat-Free Mass (FFM in kg) was calculated by subtracting this estimated fat mass from the total body mass.
|
six month
|
|
Skeletal Muscle Mass
Periodo de tiempo: six month
|
Total skeletal muscle mass (kg) was estimated by employing validated anthropometric prediction models for children and adolescents, which account for standing height as well as corrected limb girths (i.e., thigh, calf, and arm circumferences that have been corrected for their respective overlying subcutaneous adipose tissue thicknesses).
|
six month
|
|
Arm Muscle Area
Periodo de tiempo: six month
|
AMA was calculated to estimate regional upper-body muscularity and protein reserves.
AMA (cm²) was derived from relaxed arm girth (cm) and triceps skinfold thickness (cm) using the standard anthropometric equation
|
six month
|
|
Somatotype
Periodo de tiempo: six month
|
The anthropometric somatotype components, namely endomorphy, mesomorphy, and ectomorphy, were calculated according to the Heath-Carter method [17, 24]. Endomorphy was estimated based on the height-adjusted sum of three skinfold thicknesses: triceps, subscapular, and suprailiac. |
six month
|
|
Motor Performance Tests
Periodo de tiempo: six month
|
Flexibility (Sit and Reach Test): Lower-Body Explosive Power: Muscular Endurance: Speed (20-m Sprint): |
six month
|
|
Body Composition
Periodo de tiempo: 6 months
|
Endomorphy was estimated based on the height-adjusted sum of three skinfold thicknesses: triceps, subscapular, and suprailiac. Mesomorphy was determined using humerus (elbow) breadth, femur (knee) breadth, height, and corrected limb girths. Corrected arm girth (CAG) and corrected calf girth (CCG) were adjusted for the corresponding skinfold thicknesses. Ectomorphy was derived from the Height-Weight Ratio (HWR), which was calculated as height divided by the cube root of body mass. |
6 months
|
|
Weight
Periodo de tiempo: 6 Month
|
Participants were assessed barefoot and wearing minimal clothing.
Participants' body weight was measured using a Seca (Seca GmbH, Hamburg, Germany) scale with an accuracy of 0.1 kg.
|
6 Month
|
|
Height
Periodo de tiempo: 6 month
|
Participants' height was measured using a Seca (Seca GmbH, Hamburg, Germany) stadiometer with an accuracy of 0.1 cm.
|
6 month
|
|
Body Mass Index
Periodo de tiempo: 6 month
|
Participants' body mass indices (BMI) were calculated using the weight/height² formula (kg/m² ).
|
6 month
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- BanirmaOnyediEylulU
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .